×
To start your customized experience click the start button
Customize
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung

Brielle Urciuoli
To raise awareness for the striking effects the disease has on women, the LCRF recently launched two campaigns.
Kristie L. Kahl
Imagine being diagnosed at the age of 21 as a never-smoking individual and college athlete.
DEBU TRIPATHY, M.D.
THE TERM “BIOPSY” DATES to the 1800s. Tissue biopsies have served as the definitive way to confirm a diagnosis of cancer. However, much like cancer drug development is evolving, so is the way we can detect the disease, categorize it more precisely and, more recently, even pinpoint how to treat it.
MIKE HENNESSY, SR.
Genetic mutations help fuel the growth of cancer tumors in patients. And, in recent years, experts in the medical field have begun to better understand how targeting those mutations can knock out the spread of the disease.
Silas Inman
The combination delated progression or death compared to Avastin and chemotherapy alone, according to Roche, the manufacturer of the anti–PD-L1 and anti–VEGF agents.
M. CLARK, M.D., AND ELIZABETH A. DAVID, M.D., MAS, FACS
Rural patients tend to have diminished access to appropriate, routine cancer screening studies, leading to patients with cancer being diagnosed with more advanced stage disease.
ARIELA KATZ
For patients with advanced disease, median survival was improved.
Katie Kosko
A recent study found that the cost to patients with breast, lung and colorectal cancers treated in the hospital outpatient setting was nearly $8,000 more than those treated in the community setting.
DARA CHADWICK
New targeted therapies are rapidly changing the landscape of non-small cell lung cancer.
HEATHER MILLAR
Newer, less invasive tests are helping scientists isolate genomic alterations.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable